IWA
GILD icon

IBEX Wealth Advisors’s Gilead Sciences GILD Stock Holding History

IBEX Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.14M Sell
15,323
-53,231
-78% -$7.45M 0.2% 79
2025
Q4 		$8.41M Buy
68,554
+54,566
+390% +$6.63M 0.82% 36
2025
Q3 		$1.55M Buy
13,988
+1,318
+10% +$150K 0.15% 96
2025
Q2 		$1.4M Buy
+12,670
New +$1.35M 0.15% 92
2024
Q3 		– Sell
-35
Closed -$2.42K – 144
2024
Q2 		$2.42K Sell
35
-65,433
-100% -$4.37M ﹤0.01% 268
2024
Q1 		$5.62M Buy
65,468
+65,405
+103,817% +$5.03M 1.52% 28
2023
Q4 		$5.09K Sell
63
-62,149
-100% -$4.84M 1.11% 35
2023
Q3 		$4.66M Buy
+62,212
New +$4.79M 1.19% 33
2023
Q1 		$5.55M Buy
66,848
+1,380
+2% +$114K 1.44% 26
2022
Q4 		$5.62M Buy
65,468
+438
+0.7% +$34.7K 1.27% 29
2022
Q3 		$4.01M Sell
65,030
-139
-0.2% -$8.77K 1.04% 34
2022
Q2 		$4.03M Buy
65,169
+54,048
+486% +$3.35M 0.93% 40
2022
Q1 		$661K Buy
+11,121
New +$711K 0.13% 109
2020
Q2 		– Sell
-26,726
Closed -$2M – 99
2020
Q1 		$2M Buy
+26,726
New +$1.85M 0.78% 52
2017
Q1 		– Sell
-87
Closed -$6K – 184
2016
Q4 		$6K Buy
+87
New +$6.47K ﹤0.01% 353

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

IBEX Wealth Advisors's GILD Position: Q1 2026 in Review

IBEX Wealth Advisors reduced its Gilead Sciences (GILD) stake by 78% in Q1 2026, selling an estimated $7.45M and leaving 15,323 shares worth $2.14M. The position accounts for 0.2% of the portfolio, ranked #79.

IBEX Wealth Advisors first reported a position in GILD in Q4 2016 and has held it in 15 quarters since. The position peaked at $8.41M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • IBEX Wealth Advisors held 15,323 shares of Gilead Sciences worth $2.14M as of Q1 2026.
  • IBEX Wealth Advisors sold 53,231 Gilead Sciences shares in Q1 2026, an estimated $7.45M.
  • Gilead Sciences made up 0.2% of IBEX Wealth Advisors's portfolio in Q1 2026, its #79 holding.
  • IBEX Wealth Advisors first reported a position in Gilead Sciences in Q4 2016 and has held it in 15 quarters since.
  • IBEX Wealth Advisors's Gilead Sciences position peaked at $8.41M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on IBEX Wealth Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.